---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-035226"
form_type: "8-K/A"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2022-06-27T23:59:59+00:00"
generated_at: "2026-06-24T23:02:38.147094+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Pasithea amends 8-K to extend deadline for Alpha-5 Integrin financials filing

## Summary
- Original 8-K filed June 22, 2022 reported acquisition of Alpha-5 Integrin, LLC.
- This amendment confirms intent to file acquired company financials within 75 days from June 21, 2022.
- Pro forma financial information will also be filed within the same period.
- No other changes were made to the original Form 8-K.

## SEC filing metadata
- accession: 0001213900-22-035226
- form_type: 8-K/A
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2022-06-27T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390022035226/0001213900-22-035226-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390022035226/ea162141-8ka_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-035226
- JSON: https://secwatch.observer/filing/0001213900-22-035226.json
- Plain text: https://secwatch.observer/filing/0001213900-22-035226.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.